Executive incentives through performance-linked and equity compensation
First written in FY2016. 15 of 18 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-20.
The whole theme swung hardest in 2024: 13 of 118 companies on the "Worse" side.
- FY2026SoftenedAnnual report
「Total performance-linked compensation = consolidated ordinary profit for the fiscal year × 1.5%」
The calculation rate for performance-linked compensation has changed from the previously stated 3% of consolidated ordinary profit to 1.5%. The total annual payment cap is ¥50 million. - FY2024-Q2AdvancedAnnual report
「This relates to the issuance of new shares as restricted stock compensation. Issue price: ¥1,192 per share Amount transferred to stated capital: ¥596 per share Allottees: 3 Company directors, excluding directors serving as Audit and Supervisory Committee members and outside directors, 11,400 shares 4 Company executive officers, 9,200 shares」
Discloses the issuance, dated 10 August 2023, of a total of 20,600 shares as restricted stock compensation to 3 directors and 4 executive officers. - FY2024-Q1AdvancedAnnual report
「Resolution date 29 May 2023 Categories and number of grantees 3 Company directors 5 Company executive officers Number of stock acquisition rights (units)* 229 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 22,900 Exercise period for the stock acquisition rights* From 14 June 2023 To 31 May 2043」
Granted 229 stock acquisition rights covering 22,900 shares to 3 directors and 5 executive officers. The exercise period is stated as 14 June 2023 to 31 May 2043. The Company also disclosed the issuance of new shares as restricted stock compensation pursuant to the Board of Directors resolution dated 19 July 2023. - FY2023ReframedAnnual report
「At the 97th Annual General Meeting of Shareholders held on 23 June 2023, the Company resolved to change the stock compensation component from the existing stock compensation-type stock acquisition rights to restricted stock compensation.」
Disclosed, as of the filing date, the resolution to change the program from the existing stock compensation-type stock acquisition rights to restricted stock compensation. Actual ordinary profit for the 97th fiscal year was ¥1,255 million against the performance-linked compensation target of ¥860 million. - FY2023-Q1AdvancedAnnual report
「Resolution date 30 May 2022 Categories and number of grantees 3 Company directors 3 Company executive officers Number of stock acquisition rights (units)* 183 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 18,300」
Granted 183 stock compensation-type stock options covering 18,300 shares to 3 directors and 3 executive officers. - FY2022-Q2AdvancedAnnual report
「Resolution date 24 June 2021 Categories and number of grantees 3 Company directors 3 Company executive officers Number of stock acquisition rights (units)* 183 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 18,300」
Granted 183 stock compensation-type stock options covering 18,300 shares to 3 directors and 3 executive officers. - FY2021AdvancedAnnual report
「Ordinary profit for the 95th fiscal year was ¥635 million, compared with the target of ¥490 million.」
The Company specified a compensation system using consolidated ordinary profit as the performance-linked compensation metric. For the 95th fiscal year, actual ordinary profit was ¥635 million against a target of ¥490 million. - FY2021-Q1AdvancedAnnual report
「Resolution date 25 May 2020 Categories and number of grantees 3 Company directors 4 Company executive officers Number of stock acquisition rights (units)* 206 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 20,600」
For the resolution dated 25 May 2020, reports that 206 stock acquisition rights covering 20,600 shares were issued to 3 directors and 4 executive officers. - FY2020AdvancedAnnual report
「At a meeting of the Board of Directors held on 25 May 2020, the Company resolved to issue stock acquisition rights to its directors and executive officers pursuant to Articles 236, 238 and 240 of the Companies Act.」
Resolved to issue 20,600 common shares and 206 stock compensation-type stock options to 3 directors and 4 executive officers. - FY2019AdvancedAnnual report
「At a meeting of the Board of Directors held on 27 May 2019, the Company resolved to issue stock acquisition rights to its directors and executive officers pursuant to Articles 236, 238 and 240 of the Companies Act.」
Resolved to issue 206 stock acquisition rights covering 20,600 shares to 3 directors and 4 executive officers, for the period from 21 June 2019 to 31 May 2039. - FY2019-Q1AdvancedAnnual report
「Number of stock acquisition rights (units)* 183 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 18,300」
For the resolution dated 28 May 2018, reports that 183 stock acquisition rights covering 18,300 shares were issued to 3 directors and 3 executive officers on 20 June 2018. - FY2018AdvancedAnnual report
「At a meeting of the Board of Directors held on 28 May 2018, the Company resolved to issue stock acquisition rights to its directors, excluding directors serving as Audit and Supervisory Committee members, and executive officers, excluding those concurrently serving as directors, pursuant to Articles 236, 238 and 240 of the Companies Act.」
Resolved to issue 18,300 shares and 183 stock compensation-type stock options to 3 directors and 3 executive officers. - FY2018-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period pursuant to Articles 236, 238 and 240 of the Companies Act are as follows.」
Reports the issuance of 160 stock acquisition rights covering 16,000 shares pursuant to the resolution dated 29 May 2017. - FY2017AdvancedAnnual report
「At a meeting of the Board of Directors held on 29 May 2017, the Company resolved to issue stock acquisition rights to its directors, excluding directors serving as Audit and Supervisory Committee members, and executive officers, excluding those concurrently serving as directors, pursuant to Articles 236, 238 and 240 of the Companies Act.」
Resolved to issue 16,000 common shares and 160 stock compensation-type stock options to 3 directors and 2 executive officers. - FY2017-Q1AdvancedAnnual report
「Board of Directors resolution dated 30 May 2016 Number of stock acquisition rights (units) 170 Number of shares underlying the stock acquisition rights (shares) 17,000」
Reports the issuance of 170 stock acquisition rights covering 17,000 shares to 3 directors and executive officers, indicating that the stock compensation program is being implemented. - FY2016First statedAnnual report
「Regarding performance-linked compensation, the board of directors decided, after consulting with the audit and supervisory committee, to pay the 3 eligible directors the amount calculated using the formula below. (Formula) Consolidated ordinary profit for the fiscal year × 3% = Total performance-linked compensation paid (capped at ¥50 million)」
Sets performance-linked compensation at 3% of consolidated ordinary profit, capped at ¥50 million, and separately refers to stock compensation-type stock options tied to the operating profit margin.